首页> 外文期刊>Expert opinion on pharmacotherapy >Combination pharmaceutical therapies for obesity.
【24h】

Combination pharmaceutical therapies for obesity.

机译:肥胖的组合药物疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

The anti-obesity medications available at present achieve a rather modest degree of weight loss that falls below the expectations of clinicians as well as consumers. Several combination drug therapies are in development with the aim of achieving better results that would be clinically more meaningful in the reduction of obesity-related health risks. This paper discusses the pros and cons of combination therapies, and the ongoing research in this area.
机译:目前可获得的抗肥胖药物可实现相当温和的减肥程度,低于临床医生以及消费者的期望。 有几种组合药物疗法正在开发,目的是实现更好的结果,即在减少肥胖相关的健康风险方面将在临床上更有意义。 本文讨论了组合疗法的优缺点,以及该领域的持续研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号